About Tejas Translational Technologies
Tejas Translational Technologies was a Consumer company based in Nagercoil (India) founded in 2016. It operates as an online platform offering slot games, jackpots, and casino services to users. It operates on a B2C and D2C model. The company is recorded as dissolved. Tejas Translational Technologies offers products and services including Slot Games, Live Casino, and Sports Betting. Its focus areas include Entertainment, Gaming Tech, Online Gambling and Live Casino. Its legal entity in India is Tejas Translational Technologies Private Limited (U74999TN2016PTC104872). Its competitors include TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Matahari168 operates as an online gambling platform in Indonesia, providing access to various slot games, live casino, sports betting, and arcade options from multiple providers. Users can engage in transactions via local banks and e-wallets, participating in jackpots and interactive games. The service focuses on user-friendly gaming experiences while ensuring secure payments and promotions.
- Headquarters Nagercoil, India
- SectorsConsumer
- Website tejascorp.com
- Social X Facebook
- Legal Name Tejas Translational Technologies Private Limited
- Date of Incorporation 24 Mar, 2016
- Jurisdiction Kanyakumari, Tamil Nadu, India
- Annual Revenue₹54,365
FY 2025 · -77% YoY
- Net Loss-₹2.6 Lakh
FY 2025 · -477% margin
- EBITDA-₹55,747
FY 2025 · -103% margin
Associated legal entities of Tejas Translational Technologies
Tejas Translational Technologies operates through Tejas Translational Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Tejas Translational Technologies Private Limited CIN U74999TN2016PTC104872 | Active | 24 Mar 2016 | Kanyakumari, Tamil Nadu | ₹0.0 Cr | – | 2 | View details |
Products & Services of Tejas Translational Technologies
Tejas Translational Technologies offers a comprehensive portfolio of products and services, including Slot Games, Live Casino, and Sports Betting.
Platform for playing various slot games with jackpots and rewards
Real-time casino games featuring dealers and interactive play
Service for wagering on sports events through the platform
Board of directors of Tejas Translational Technologies Private Limited (Tejas Translational Technologies)
Tejas Translational Technologies Private Limited is the primary company behind Tejas Translational Technologies. The board of Tejas Translational Technologies Private Limited currently have 2 directors; the longest-serving is Perumal Pillai Ponram, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Perumal Pillai Ponram DIN 07418191 | Director | 24 Mar 2016 | 10 yrs 6 mo | Tejas Translational Technologies Private Limited |
| Athithiya Vinod Kumar Shoba DIN 09050728 | Director | 31 Dec 2020 | 5 yrs 9 mo | Tejas Translational Technologies Private Limited |
Financials of Tejas Translational Technologies
Figures of Tejas Translational Technologies Private Limited, the primary company behind Tejas Translational Technologies, for FY 2025. Revenue was ₹54,365 (-77% year on year). Net loss was -₹2.6 Lakh (-477% margin). EBITDA was -₹55,747 (-103% margin). Revenue has grown at a compounded annual rate of -54% over three years and -38% over five years.
- ₹54,365Revenue · FY 2025 · -77% YoY
- -₹2.6 LakhNet loss · -477% margin
- -₹55,747EBITDA · -103% margin
- ₹1 LakhPaid-up capital
- -54%Revenue CAGR, 3 years
- -38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Tejas Translational Technologies Private Limited are on its company page.
Detailed financial statements for Tejas Translational Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Tejas Translational Technologies
Tejas Translational Technologies has 10 listed competitors in our database, 9 of them funded. They include TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tissium.com | 2013 | Paris, France | $155.98M | – | Vascular sealants for open surgery are developed by TISSIUM. | |
| laminatemedical.com | 2012 | Rehovot, Israel | $20M | – | AV fistula maturation and patency are supported by VasQ device. | |
| vivasuremedical.com | 2009 | Galway, Ireland | $92.08M | – | Bioabsorbable implants and delivery systems for arteriotomy closure are developed. | |
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| saranas.com | 2011 | Houston, United States | $29.46M | – | A device is developed for detecting internal bleeding during catheterization. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| innavasc.com | 2013 | Durham, United States | $3.34M | – | Synthetic vascular grafts with self-sealing chambers for hemodialysis are developed. | |
| ekoscorp.com | 1995 | Bothell, United States | $58.8M | – | Ultrasound thrombolytic devices for pulmonary embolism treatment are developed. | |
| figure8surgical.com | 2009 | Palo Alto, United States | $43.1M | – | Offers a sternal closure system designed for open-heart surgery patients. | |
| cordis.com | 1957 | Fremont, United States | – | 5 | Cardiovascular and endovascular devices are developed and marketed by Cordis. |
Detailed competitors of Tejas Translational Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Gambling & Entertainment Platforms
10 companies that operate in the same segment as Tejas Translational Technologies (Gambling & Entertainment Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Licensed sports merchandise, collectibles, and betting platforms are provided. | 2011 | New York, New York, United States | USD 4.85 B | – | 14,656 | |
Online skill-based games are developed across platforms and genres. | 2010 | Delhi, Delhi, India | USD 1.79 M | USD 166.95 M | 699 | |
Mobile casino games with social features are developed for platforms. | 2014 | Warsaw, Poland | USD 8.6 M | USD 246.28 M | 428 | |
An online platform for skill-based gaming competitions is provided. | 2019 | Gurugram, Haryana, India | USD 25.96 M | USD 11.28 M | 39 | |
Provider of online skill-based gaming platforms | 2005 | Hyderabad, Telangana, India | USD 81.87 M | USD 128.91 M | 529 | |
Developer of a micro-betting platform for sports | 2022 | Miami, Florida, United States | USD 102 M | – | – | |
Provider of a P2P sports betting platform | 2021 | New York, New York, United States | USD 75 M | – | 94 | |
Multi-category online gambling is facilitated via an app-based platform. | 1934 | London, England, United Kingdom | – | USD 1.71 B | 10,239 | |
Online platform for betting on multiple sports is provided. | 2001 | Stoke On Trent, England, United Kingdom | – | – | – | |
Casual mobile games are developed and published by SciPlay. | 2007 | London, England, United Kingdom | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tejas Translational Technologies
Complete news archive for Tejas Translational Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejas Translational Technologies
Tejas Translational Technologies was founded in 2016.
Tejas Translational Technologies is headquartered in Nagercoil, India. It is registered at Nagercoil, Tamil Nadu, India.
The primary company behind Tejas Translational Technologies, Tejas Translational Technologies Private Limited, reported revenue of ₹54,365 for FY 2025, down 77% year on year.
Matahari168 operates as an online gambling platform in Indonesia, providing access to various slot games, live casino, sports betting, and arcade options from multiple providers. Users can engage in transactions via local banks and e-wallets, participating in jackpots and interactive games. The service focuses on user-friendly gaming experiences while ensuring secure payments and promotions.
Tejas Translational Technologies's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Tejas Translational Technologies offers Slot Games, Live Casino, and Sports Betting.
Tejas Translational Technologies operates through Tejas Translational Technologies Private Limited.
The legal entities of Tejas Translational Technologies currently have 2 directors, including Perumal Pillai Ponram, Athithiya Vinod Kumar Shoba.